CompletedNot Applicable

Light Treatment of Vaginal Infections in Reproductive Age Women

Denmark38 participantsStarted 2025-06-05

Plain-language summary

Antimicrobials have helped in managing vaginal dysbiotic conditions such as bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC). However, their increasing inefficiency and rise in antimicrobial resistance (AMR) is a challenge and threat to public health. Therefore, this study will investigate the safety and efficacy of light as an antimicrobial to treat vulvovaginal infections.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-45 years of age * Normal gynecological status * Diagnosed for BV or VVC * Not pregnant * No signs of other genital tract infections Exclusion Criteria: * Current signs of other genital tract infection including STD * Concomitant medication for treatment of vaginal infections or use of any intravaginal medication during the clinical investigation * Pregnancy * Current genital malignancies, chemotherapy for any reason within the last 6 months, previous radiotherapy in the genitourinary system. Cervical dysplasia diagnosis or treatment within the last 3 months (where applicable)

What they're measuring

Patient reported reduction in symptoms of BV/VVC

Timeframe: Upto 2 months

Trial details

NCT IDNCT06985433

SponsorUVISA Health ApS

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-12-29

View on ClinicalTrials.gov More Bacterial Vaginosis trials